Profile data is unavailable for this security.
About the company
Ind Swift Limited is an India-based company, which is engaged in manufacturing and trading of pharmaceutical and healthcare products. The Company's divisions include Nova Division, Ethical Division, Generic Division, and Ayurveda Division. The Nova Division is a multispecialty division. Its portfolio covers all the therapeutic segments which are available in all the other divisions like respiratory inclusive of ENT, dentistry, anti-infective, cardio-diabetic and orthopedic therapies. The Nova Division Products include Aclovin, Aclovin - SR, Adelive oil and Agipod D/S. The Ethical Division is focused on gynecology, pediatrics, dermatology and GP and its ambit extends to a wide range of medicines. The Generic Division is divided into various therapeutic segments, namely antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial and anti-depressants. The Ayurveda Division's products include Swift Hangover Capsules, Oliade Oil, Swift Tulsi Drops and Majitrich Capsules.
- Revenue in INR (TTM)4.68bn
- Net income in INR401.08m
- Incorporated1986
- Employees1.67k
- LocationInd Swift Ltd781, Industrial Area,Phase II,CHANDIGARH 160002IndiaIND
- Phone+91 1 724680800
- Fax+91 1 722652242
- Websitehttp://www.indswiftltd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biofil Chemicals and Pharmaceuticals Ltd | 460.45m | 6.34m | 1.22bn | -- | 188.74 | -- | 119.22 | 2.65 | 0.3978 | 0.3978 | 28.96 | -- | -- | -- | -- | -- | -- | 2.74 | -- | 5.36 | 4.94 | 9.99 | 1.38 | 2.80 | -- | 7.63 | -- | -- | 33.29 | 11.60 | 26.55 | 8.02 | -56.15 | -- |
Ind Swift Ltd | 4.68bn | 401.08m | 1.23bn | 1.67k | 3.07 | -- | 1.87 | 0.2636 | 7.42 | 7.42 | 86.37 | -- | -- | -- | -- | -- | -- | -0.902 | -- | -- | 45.63 | 45.72 | 8.58 | -1.44 | -- | 0.1318 | -- | -- | 22.21 | 11.68 | -45.34 | 11.68 | 15.24 | -- |
Lasa Supergenerics Ltd | 1.05bn | -195.13m | 1.35bn | 77.00 | -- | -- | -- | 1.29 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
Vaidya Sane Ayurved Laboratories Ltd | 993.31m | 19.80m | 1.49bn | 636.00 | 84.90 | 2.67 | 28.94 | 1.50 | 1.66 | 1.66 | 78.54 | 52.89 | 1.58 | 6.83 | 15.11 | 1,561,813.00 | 3.16 | 4.83 | 4.02 | 7.49 | 74.12 | 70.91 | 2.00 | 2.53 | 2.11 | 5.49 | 0.0293 | -- | 0.1638 | 9.71 | -59.02 | 31.91 | 4.43 | -- |
Sotac Pharmaceuticals Ltd | 1.10bn | 37.21m | 1.52bn | 89.00 | 40.75 | -- | 21.34 | 1.38 | 3.37 | 3.37 | 99.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.53 | -- | 3.38 | -- | -- | 2.75 | -- | -- | 79.07 | -- | -20.38 | -- | -- | -- |